People with a rare disease have equitable access to treatments when recommended by each nation's health and care guidance body. Access to new treatments is subject to nation-specific commissioning ...
People diagnosed with a rare disease or with a suspected rare disease that remains undiagnosed after diagnostic investigations are supported to make shared decisions throughout all stages of care. The ...